Jim Simons Enochian Biosciences Inc Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.42 - $9.0 $399,369 - $813,195	-90,355 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.71 - $12.55 $606,282 - $1.13 Million	90,355 New	90,355 $659,000
Q1 2021 May 13, 2021	SELL	$3.02 - $4.51 $167,308 - $249,854	-55,400 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.82 - $3.55 $156,228 - $196,670	55,400 New	55,400 $163,000
Q1 2020 May 14, 2020	SELL	$2.08 - $5.41 $23,920 - $62,215	-11,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.48 - $6.75 $40,020 - $77,625	11,500 New	11,500 $58,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.